Author details

Full Name

David Tamborero

Affiliation

Universitat Pompeu Fabra

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36697832	Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.	Nature	2023
35101336	Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).	Genet Med	2022
36063163	Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).	Genet Med	2022
32675227	Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.	Haematologica	2021
34994625	Discordant Reporting of a Previously Undescribed Pathogenic Germline <i>BRCA2</i> Variant in Blood and Tumor Tissue in a Patient With Pancreatic Adenocarcinoma.	JCO Precis Oncol	2021
34870237	Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.	Nat Cancer	2021
33992745	Genomic testing for targeted oncology drugs: hopes against hype.	Ann Oncol	2021
32246132	A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.	Nat Genet	2020
30523021	NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.	Clin Cancer Res	2019
30209402	CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.	Leukemia	2019
28804123	Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.	Leukemia	2018
30096302	Comprehensive Characterization of Cancer Driver Genes and Mutations.	Cell	2018
29666300	A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.	Clin Cancer Res	2018
29625053	Comprehensive Characterization of Cancer Driver Genes and Mutations.	Cell	2018
29592813	Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.	Genome Med	2018
27795554	Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia.	Leukemia	2017
28138153	CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.	Nat Genet	2017
28915594	Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing.	Oncotarget	2017
28619982	JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.	Blood	2017
28714987	Comparison of algorithms for the detection of cancer drivers at subgene resolution.	Nat Methods	2017
27397505	A Landscape of Pharmacogenomic Interactions in Cancer.	Cell	2016
27716338	Rational design of cancer gene panels with OncoPaD.	Genome Med	2016
25501392	Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.	Nat Genet	2015
26200345	Non-coding recurrent mutations in chronic lymphocytic leukaemia.	Nature	2015
25759023	In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities.	Cancer Cell	2015
24265505	Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.	Genome Res	2014
25109877	Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.	Cell	2014
25161255	Fast randomization of large genomic datasets while preserving alteration counts.	Bioinformatics	2014
25161246	OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.	Bioinformatics	2014
23408991	Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.	PLoS One	2013
24037244	IntOGen-mutations identifies cancer drivers across tumor types.	Nat Methods	2013
24084849	Comprehensive identification of mutational cancer driver genes across 12 tumor types.	Sci Rep	2013
23884480	OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes.	Bioinformatics	2013
21186230	Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory?	Europace	2011
21906703	Effect of repeated radiofrequency catheter ablation on left atrial function for the treatment of atrial fibrillation.	Am J Cardiol	2011
21635609	Electrocardiographic versus echocardiographic optimization of the interventricular pacing delay in patients undergoing cardiac resynchronization therapy.	J Cardiovasc Electrophysiol	2011
21438894	Comparison of hemodynamic versus dyssynchrony assessment for interventricular delay optimization with echocardiography in cardiac resynchronization therapy.	Pacing Clin Electrophysiol	2011
19880855	Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.	Europace	2010
20488856	Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.	Europace	2010
20543199	Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment.	Europace	2010
20193794	Circumferential pulmonary vein ablation: does use of a circular mapping catheter improve results? A prospective randomized study.	Heart Rhythm	2010
20360066	Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy.	Eur J Heart Fail	2010
20350704	Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration.	J Card Fail	2010
19923171	Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes.	Europace	2010
19268755	Electrocardiographic optimization of cardiac resynchronization devices: simple, but not so simple!	Am J Cardiol	2009
19892059	Optimization of the interventricular delay in cardiac resynchronization therapy using the QRS width.	Am J Cardiol	2009
19880850	Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mapping.	Europace	2009
19808466	Noninvasive evaluation of radiofrequency lesions in the human ventricular myocardium by contrast-enhanced cardiac magnetic resonance.	Circ Arrhythm Electrophysiol	2009
19808442	Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study.	Circ Arrhythm Electrophysiol	2009
19487235	Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial.	Eur Heart J	2009

1 - 50 of 70

Brian Tsui

David Geffen School of Medicine at university of california los angeles

Career Start Year 2016

Number of shared co-authors 1

Qurat Ul Ain Riaz Sipra

Banner University Medical Center, University of Arizona

Career Start Year 2015

Number of shared co-authors 0

Irbaz Bin Riaz

Mayo Clinic

Career Start Year 2012

Number of shared co-authors 2

Inna Y Gong

University of Toronto

Career Start Year 2010

Number of shared co-authors 0

Hayan Jouni

Mayo Clinic

Career Start Year 2010

Number of shared co-authors 0

Haibo Zhang

Keenan Research Centre for Biomedical Science of St. Michael's Hospital

Career Start Year 2010

Number of shared co-authors 0

Jessica Minnier

Louis Stokes Cleveland VA Medical Center Cleveland

Career Start Year 2010

Number of shared co-authors 1

Konstantinos C Siontis

Mayo Clinic

Career Start Year 2010

Number of shared co-authors 0

Albert Y Sun

Duke University Medical Center

Career Start Year 2009

Number of shared co-authors 0

Vikram Agarwal

University of Washington

Career Start Year 2008

Number of shared co-authors 0

Victoria N Parikh

Stanford University

Career Start Year 2005

Number of shared co-authors 1

Keyue Ding

Queen's University

Career Start Year 2002

Number of shared co-authors 0

Joseph G Akar

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital

Career Start Year 2001

Number of shared co-authors 0

Pingfu Fu

Case Western Reserve University

Career Start Year 2000

Number of shared co-authors 0

Christopher G Scott

Mayo Clinic

Career Start Year 1999

Number of shared co-authors 3

Renaud Seigneuric

INSERM

Career Start Year 1997

Number of shared co-authors 0

Moore Benjamin Shoemaker

Vanderbilt University Medical Center

Career Start Year 1997

Number of shared co-authors 0

Naveen L Pereira

Mayo Clinic

Career Start Year 1997

Number of shared co-authors 1

Nam Bui

Stanford University

Career Start Year 1996

Number of shared co-authors 1

Christian Baumgartner

Institut fur Experimentelle und Angewandte Physik, University of Regensburg

Career Start Year 1994

Number of shared co-authors 0

Joydeep Ghosh

Tata Medical Center

Career Start Year 1993

Number of shared co-authors 0

Euan A Ashley

Stanford University

Career Start Year 1993

Number of shared co-authors 4

Calum A MacRae

Harvard Medical School and Cardiovascular Division, Brigham and Women's Hospital

Career Start Year 1991

Number of shared co-authors 1

Patrick T Ellinor

Cardiovascular Research Center, Massachusetts General Hospital

Career Start Year 1989

Number of shared co-authors 4

Daniel J Friedman

Duke Clinical Research Institute, Duke University School of Medicine

Career Start Year 1988

Number of shared co-authors 0

Ju Han Kim

The Korea Cardiovascular Stent Research Institute, Chonnam National University

Career Start Year 1987

Number of shared co-authors 3

Catherine Klersy

Biostatistics & Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo

Career Start Year 1981

Number of shared co-authors 0

Francisco Fern??ndez-Avil??s

Gregorio Maranon University Hospital

Career Start Year 1980

Number of shared co-authors 0

Paul A Friedman

Mayo Clinic

Career Start Year 1968

Number of shared co-authors 0

row(s) 1 - 29 of 29

Nuria Lopez-Bigas

Universitat Pompeu Fabra

Co-authored papers 23

Abel Gonzalez-Perez

Universitat Pompeu Fabra

Co-authored papers 15

Gad Getz

Broad Institute of the Massachusetts Institute of Technology and Harvard

Co-authored papers 6

Jordi Deu-Pons

Institute for Research in Biomedicine

Co-authored papers 6

Rodrigo Dienstmann

Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus

Co-authored papers 5

Michael S Lawrence

Co-authored papers 5

Li Ding

McDonnell Genome Institute, Washington University School of Medicine

Co-authored papers 5

Obi L Griffith

Washington University

Co-authored papers 4

Alex H Wagner

Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis

Co-authored papers 4

Joshua M Stuart

University of California at Santa Cruz

Co-authored papers 4

Kilannin Krysiak

Washington University School of Medicine

Co-authored papers 4

Malachi Griffith

Washington University

Co-authored papers 4

Damian T Rieke

German Cancer Consortium and German Cancer Research Center